A man was injured in a stabbing during an altercation on Chicago's CTA Blue Line. The victim was taken to the hospital and is in good condition. No arrests have been made, and police are investigating.

A new ranking puts Chicago at No. 9 for startups — strong survival rates, but the city lags in new business formation.

A computational mismatch helped researchers identify residual water blocking COF capture sites — making pores hydrophobic during synthesis restores CO2 uptake.

An international 4D Nucleome team produced single‑cell 3D genome maps, cataloging 140,000+ chromatin loops and offering new ways to link non‑coding variants to disease.

Northwestern researchers report NU‑9 lowered a newly discovered toxic amyloid‑beta oligomer and blunted early brain inflammation in mice, pointing to a possible pre‑symptomatic intervention.

Chicago Christian students finished first and second at the South Suburban robotics meet and were tapped to represent Illinois at the United States Governor's Cup in D.C.

NMSU and Northwestern astronomers reprocessed archived telescope data to directly image HD 143811 AB b — a roughly five‑Jupiter‑mass planet orbiting twin stars. The find gives a rare window into planet formation around binaries.

Syntax Bio's Science Advances paper introduces 'Cellgorithm', a CRISPR-based method that the company says can shrink stem-cell differentiation from months to days. The approach could speed regenerative therapies if it scales.

The Harold B. Smith Foundation has made the largest gift ever to Rush MD Anderson, establishing a new research center to expand early‑stage cancer trials in Chicago.

Illinois state agencies warn residents of increased cyber scams during the holidays and provide tips for safe online shopping, emphasizing the importance of verifying links, reading reviews, using credit cards, and monitoring financial activities.

GE HealthCare will buy Montreal-based Intelerad for $2.3 billion in cash to expand cloud and AI imaging tools. The deal is expected to close in the first half of 2026.

The FDA approved AbbVie and Genmab’s Epkinly with rituximab and lenalidomide after a Phase 3 trial showed large, durable responses in relapsed follicular lymphoma. The label includes boxed warnings for CRS and ICANS.

Abbott is reportedly closing in on Exact Sciences, the maker of Cologuard, in a multibillion‑dollar deal that would boost its cancer‑diagnostics footprint. Talks are ongoing and could produce a formal announcement soon.